Overview

Dr. Amid received his medical degree from the Tehran University of Medical Sciences and completed his pediatric residency at the University of Calgary, followed by his pediatric hematology/oncology fellowship at the University of Ottawa and University of Toronto. Dr. Amid subsequently completed a clinical and research fellowship in hemoglobinopathies and iron overload disorders at the Hospital for Sick Children (SickKids) in Toronto. Prior to moving to Vancouver and starting his current role as a Pediatric Hematologist at BC Children’s Hospital in 2021, he was an Assistant Professor of Pediatrics at the University of Ottawa and a Pediatric Hematologist at Children’s Hospital of Eastern Ontario.

A BCCH, he is the Director of the Hemoglobinopathy and Iron Overload Clinic.

Publications

Outcomes of haemoglobin Bart’s hydrops fetalis following intrauterine transfusion in Ontario, Canada
Archives of Disease in Childhood - Fetal and Neonatal Edition
Hui Jue Zhang and Ali Amid and Laura A Janzen and Catherine I Segbefia and Shiyi Chen and Uma Athale and Karen Charpentier and Manuela Merelles-Pulcini and Gareth Seaward and Edmond N Kelly and Isaac Odame and John S Waye and Greg Ryan and Melanie Kirby-Allen
DOI: 10.1136/archdischild-2019-317626
01/2021

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
The Lancet. Haematology
DOI: 10.1016/s2352-3026(20)30368-9
PubMed: 33290737
12/2020

Drisapersen associated with elevated serum factor VIII levels in Duchenne muscular dystrophy
Neurology
DOI: 10.1212/wnl.0000000000009139
03/2020

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Blood
DOI: 10.1182/blood.2019000998
PubMed: 31805182
02/2020

Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study.
The Lancet. Haematology
DOI: 10.1016/s2352-3026(18)30224-2
PubMed: 30772417
02/2019

Mild Hereditary Spherocytosis without Accompanying Hereditary Haemochromatosis: An Unrecognised Cause of Iron Overload
Acta Haematologica
Soumitra Tole and Ali Amid and Jillian Baker and Kevin Kuo and Jakob Pugi and Manuel Carcao
DOI: 10.1159/000497175
2019

Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.
Haematologica
DOI: 10.3324/haematol.2017.178368
01/2018

An international registry of survivors with Hb Bart's hydrops fetalis syndrome.
Blood
DOI: 10.1182/blood-2016-08-697110
03/2017

Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis
Blood
Ali Amid and Shiyi Chen and William Brien and Melanie Kirby-Allen and Isaac Odame
DOI: 10.1182/blood-2015-10-673889
03/2016

Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis
Blood
DOI: http://dx.doi.org/10.1182/blood-2015-10-673889
2016

Thalassaemia in children: From quality of care to quality of life
Archives of Disease in Childhood
Amid, A. and Saliba, A.N. and Taher, A.T. and Klaassen, R.J.
DOI: 10.1136/archdischild-2014-308112
2015

Presentation of Central Nervous System Tumours
Pediatric Neuro-Oncology
2015

Screening for thalassemia carriers in populations with a high rate of iron deficiency: Revisiting the applicability of the mentzer index and the effect of iron deficiency on Hb A2 levels
Hemoglobin
Amid, A. and Haghi-Ashtiani, B. and Kirby-Allen, M. and Haghi-Ashtiani, M.T.
DOI: 10.3109/03630269.2015.1024321
2015

Hb S/ß+-thalassemia due to Hb sickle and a novel deletion of dnase I hypersensitive sites HS3 and HS4 of the ß locus control region
Haematologica
Amid, A. and Cheong, M. and Eng, B. and Hanna, M. and Hohenadel, B.-A. and Nakamura, L.M. and Walker, L. and Odame, I. and Kirby-Allen, M. and Waye, J.S.
DOI: 10.3324/haematol.2014.117408
2015

Improving outcomes in children with sickle cell disease: Treatment considerations and strategies
Pediatric Drugs
Amid, A. and Odame, I.
DOI: 10.1007/s40272-014-0074-4
2014

Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients
Pediatric Blood and Cancer
Amid, A. and Barrowman, N. and Vijenthira, A. and Lesser, P. and Mandel, K. and Ramphal, R.
DOI: 10.1002/pbc.24629
2013

Evans syndrome secondary to HIV infection
Journal of Pediatric Hematology/Oncology
Amid, A. and Leung, E.
DOI: 10.1097/MPH.0b013e3182a05a93
2013

Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma
Current Oncology
Lafay-Cousin, L. and Bouffet, E. and Hawkins, C. and Amid, A. and Huang, A. and Mabbott, D.J.
2009

Thalassemia in Iran: Epidemiology, prevention, and management
Journal of Pediatric Hematology/Oncology
Abolghasemi, H. and Amid, A. and Zeinali, S. and Radfar, M.H. and Eshghi, P. and Rahiminejad, M.S. and Ehsani, M.A. and Najmabadi, H. and Akbari, M.T. and Afrasiabi, A. and Akhavan-Niaki, H. and Hoorfar, H.
DOI: 10.1097/MPH.0b013e3180437e02
2007

International medical response to a natural disaster: Lessons learned from the bam earthquake experience
Prehospital and Disaster Medicine
Abolghasemi, H. and Radfar, M.H. and Khatami, M. and Nia, M.S. and Amid, A. and Briggs, S.M.
DOI: 10.1017/S1049023X00003599
2006

Clinical quiz
Journal of Pediatric Gastroenterology and Nutrition
Abolghasemi, H. and Kavehmanesh, Z. and Matinzadeh, Z.K. and Amid, A. and Ahmadi, M.
2005

Factor XIII deficiency in south-east Iran
Haemophilia
Eshghi, P. and Abolghasemi, H. and Sanei-Moghaddam, H. and Anwar, R. and Jazebi, M. and Amid, A. and Ala, F.A.
DOI: 10.1111/j.1365-2516.2004.00951.x
2004

An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates
Clinical Biochemistry
Abolghasemi, H. and Mehrani, H. and Amid, A.
DOI: 10.1016/j.clinbiochem.2003.11.010
2004

Research

Current Projects
Dr. Amid’s area of clinical and research interest is in the field of thalassemia, sickle cell disease, iron overload, and thrombosis, and he collaborates with other researchers on a national and international level. He is the principal investigator of an international collaborative research study in thalassemia (IntercontinenTHAL study), and a member of the Hemoglobin Bart’s Hydrops Fetalis Consortium and the International Pediatric Thrombosis Network. He has participated in numerous academic and registered clinical trials.

Honours & Awards

Dr. Amid has been the recipient of many research and clinical awards (e.g. Thalassemia Foundation of Canada Research Grant) and his research has been published in leading hematology journals like Blood, Lancet Haematology and Haematologica.